Inflammasome signaling pathways exert antiviral effect against Chikungunya virus in human dermal fibroblasts

Infection, Genetics and Evolution

Volumn 32, Issue , 2015, Pages 401-408

  Ekchariyawat, Peeraya ^a   Hamel, Rodolphe ^a   Bernard, Eric ^b   Wichit, Sineewanlaya ^a   Surasombatpattana, Pornapat ^c   Talignani, Loïc ^a   Thomas, Frédéric ^a   Choumet, Valérie ^d   Yssel, Hans ^e   Desprès, Philippe ^f   Briant, Laurence ^b   Missé, Dorothée ^a  

^a CNRS   (France)

^b University of Montpellier I and II   (France)

^c PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^d INSTITUT PASTEUR   (France)

^e Assistance publique Hôpitaux de Paris   (France)

^f UNIVERSITÉ DE LA RÉUNION   (France)

Author keywords

AIM2; Arbovirus; Caspase 1; Chikungunya virus; Inflammasome; West Nile virus

Indexed keywords

ABSENT IN MELANOMA 2; CELL PROTEIN; CHEMOKINE; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INFLAMMASOME; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MELANOMA DIFFERENTIATION ASSOCIATED GENE 5 PROTEIN; OLIGOADENYLATE SYNTHETASE; RANTES; RETINOIC ACID INDUCIBLE PROTEIN I; UNCLASSIFIED DRUG; AIM2 PROTEIN, HUMAN; BETA INTERFERON; DNA BINDING PROTEIN; INTERFERON;

ANTIVIRAL ACTIVITY; ARTICLE; CHIKUNGUNYA ALPHAVIRUS; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME INHIBITION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INNATE IMMUNITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SKIN FIBROBLAST; TRANSCRIPTION REGULATION; UPREGULATION; VIRUS INFECTION; VIRUS INHIBITION; VIRUS PARTICLE; VIRUS REPLICATION; WEST NILE FLAVIVIRUS; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CHIKUNGUNYA VIRUS; FIBROBLAST; GENE SILENCING; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; VIROLOGY; WEST NILE VIRUS;

ARBOVIRUS; ARTHROPODA; CHIKUNGUNYA VIRUS; VERTEBRATA; WEST NILE VIRUS;

CASPASE 1; CELLS, CULTURED; CHEMOKINES; CHIKUNGUNYA VIRUS; DNA-BINDING PROTEINS; FIBROBLASTS; GENE SILENCING; HUMANS; INFLAMMASOMES; INTERFERON-BETA; INTERFERONS; INTERLEUKIN-1BETA; SIGNAL TRANSDUCTION; UP-REGULATION; VIRUS REPLICATION; WEST NILE VIRUS;

EID: 84927159089     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2015.03.025     Document Type: Article

References (41)

1. Aachoui Y., Sagulenko V., Miao E.A., Stacey K.J. Inflammasome-mediated pyroptotic and apoptotic cell death, and defense against infection. Curr. Opin. Microbiol. 2013, 16:319-326.
2. Arnold S.J., Osvath S.R., Hall R.A., King N.J., Sedger L.M. Regulation of antigen processing and presentation molecules in West Nile virus-infected human skin fibroblasts. Virology 2004, 324:286-296.
3. Bernard E., Solignat M., Gay B., Chazal N., Higgs S., Devaux C., Briant L. Endocytosis of Chikungunya virus into mammalian cells: role of clathrin and early endosomal compartments. PLoS ONE 2010, 5:e11479.
4. Briant L., Despres P., Choumet V., Misse D. Role of skin immune cells on the host susceptibility to mosquito-borne viruses. Virology 2014, 464-465:26-32.
5. Burt F.J., Rolph M.S., Rulli N.E., Mahalingam S., Heise M.T. Chikungunya: a re-emerging virus. Lancet 2012, 379:662-671.
6. Bustos-Arriaga J., Garcia-Machorro J., Leon-Juarez M., Garcia-Cordero J., Santos-Argumedo L., Flores-Romo L., Mendez-Cruz A.R., Juarez-Delgado F.J., Cedillo-Barron L. Activation of the innate immune response against DENV in normal non-transformed human fibroblasts. PLoS Negl. Trop. Dis. 2011, 5:e1420.
7. Chow A., Her Z., Ong E.K., Chen J.M., Dimatatac F., Kwek D.J., Barkham T., Yang H., Renia L., Leo Y.S., Ng L.F. Persistent arthralgia induced by Chikungunya virus infection is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor. J. Infect. Dis. 2011, 203:149-157.
8. Fink J., Gu F., Ling L., Tolfvenstam T., Olfat F., Chin K.C., Aw P., George J., Kuznetsov V.A., Schreiber M., Vasudevan S.G., Hibberd M.L. Host gene expression profiling of dengue virus infection in cell lines and patients. PLoS Negl. Trop. Dis. 2007, 1:e86.
9. Fredericksen B.L., Keller B.C., Fornek J., Katze M.G., Gale M. Establishment and maintenance of the innate antiviral response to West Nile Virus involves both RIG-I and MDA5 signaling through IPS-1. J. Virol. 2008, 82:609-616.
10. Gould E.A., Gallian P., De Lamballerie X., Charrel R.N. First cases of autochthonous dengue fever and chikungunya fever in France: from bad dream to reality!. Clin. Microbiol. Infect. 2010, 16:1702-1704.
11. Hoarau J.J., Jaffar Bandjee M.C., Krejbich Trotot P., Das T., Li-Pat-Yuen G., Dassa B., Denizot M., Guichard E., Ribera A., Henni T., Tallet F., Moiton M.P., Gauzere B.A., Bruniquet S., Jaffar Bandjee Z., Morbidelli P., Martigny G., Jolivet M., Gay F., Grandadam M., Tolou H., Vieillard V., Debre P., Autran B., Gasque P. Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response. J. Immunol. 2010, 184:5914-5927.
12. Hoover L.I., Fredericksen B.L. IFN-dependent and -independent reduction in West Nile virus infectivity in human dermal fibroblasts. Viruses 2014, 6:1424-1441.
13. Kelvin A.A., Banner D., Silvi G., Moro M.L., Spataro N., Gaibani P., Cavrini F., Pierro A., Rossini G., Cameron M.J., Bermejo-Martin J.F., Paquette S.G., Xu L., Danesh A., Farooqui A., Borghetto I., Kelvin D.J., Sambri V., Rubino S. Inflammatory cytokine expression is associated with chikungunya virus resolution and symptom severity. PLoS Negl. Trop. Dis. 2011, 5:e1279.
14. Kimkong I., Avihingsanon Y., Hirankarn N. Expression profile of HIN200 in leukocytes and renal biopsy of SLE patients by real time RT-PCR. Lupus 2009, 18:1066-1072.
15. Kumar M., Roe K., Orillo B., Muruve D.A., Nerurkar V.R., Gale M., Verma S. Inflammasome adaptor protein Apoptosis-associated speck-like protein containing CARD (ASC) is critical for the immune response and survival in west Nile virus encephalitis. J. Virol. 2013, 87:3655-3667.
16. Kurane I., Janus J., Ennis F.A. Dengue virus infection of human skin fibroblasts in vitro production of IFN-beta, IL-6 and GM-CSF. Arch. Virol. 1992, 124:21-30.
17. Malvy D., Ezzedine K., Mamani-Matsuda M., Autran B., Tolou H., Receveur M.C., Pistone T., Rambert J., Moynet D., Mossalayi D. Destructive arthritis in a patient with chikungunya virus infection with persistent specific IgM antibodies. BMC Infect. Dis. 2009, 9:200.
18. Mashimo T., Lucas M., Simon-Chazottes D., Frenkiel M.P., Montagutelli X., Ceccaldi P.E., Deubel V., Guenet J.L., Despres P. A nonsense mutation in the gene encoding 2'-5'-oligoadenylate synthetase/L1 isoform is associated with West Nile virus susceptibility in laboratory mice. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:11311-11316.
19. Ng L.F., Chow A., Sun Y.J., Kwek D.J., Lim P.L., Dimatatac F., Ng L.C., Ooi E.E., Choo K.H., Her Z., Kourilsky P., Leo Y.S. IL-1beta, IL-6, and RANTES as biomarkers of Chikungunya severity. PLoS ONE 2009, 4:e4261.
20. Patramool S., Surasombatpattana P., Luplertlop N., Seveno M., Choumet V., Thomas F., Misse D. Proteomic analysis of an Aedes albopictus cell line infected with Dengue serotypes 1 and 3 viruses. Parasit Vectors 2011, 4:138.
21. Qi Y., Li Y., Zhang L., Huang J. MicroRNA expression profiling and bioinformatic analysis of dengue virusinfected peripheral blood mononuclear cells. Mol. Med. Rep. 2013, 7:791-798.
22. Qian F., Chung L., Zheng W., Bruno V., Alexander R.P., Wang Z., Wang X., Kurscheid S., Zhao H., Fikrig E., Gerstein M., Snyder M., Montgomery R.R. Identification of genes critical for resistance to infection by West Nile virus using RNA-Seq analysis. Viruses 2013, 5:1664-1681.
23. Quicke K.M., Suthar M.S. The innate immune playbook for restricting West Nile virus infection. Viruses 2013, 5:2643-2658.
24. Ramos H.J., Lanteri M.C., Blahnik G., Negash A., Suthar M.S., Brassil M.M., Sodhi K., Treuting P.M., Busch M.P., Norris P.J., Gale M. IL-1beta signaling promotes CNS-intrinsic immune control of West Nile virus infection. PLoS Pathog. 2012, 8:e1003039.
25. Rathakrishnan A., Wang S.M., Hu Y., Khan A.M., Ponnampalavanar S., Lum L.C., Manikam R., Sekaran S.D. Cytokine expression profile of dengue patients at different phases of illness. PLoS ONE 2012, 7:e52215.
26. Rathinam V.A., Jiang Z., Waggoner S.N., Sharma S., Cole L.E., Waggoner L., Vanaja S.K., Monks B.G., Ganesan S., Latz E., Hornung V., Vogel S.N., Szomolanyi-Tsuda E., Fitzgerald K.A. The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat. Immunol. 2010, 11:395-402.
27. Rezza G., Nicoletti L., Angelini R., Romi R., Finarelli A.C., Panning M., Cordioli P., Fortuna C., Boros S., Magurano F., Silvi G., Angelini P., Dottori M., Ciufolini M.G., Majori G.C., Cassone A. Infection with chikungunya virus in Italy: an outbreak in a temperate region. Lancet 2007, 370:1840-1846.
28. Schilte C., Buckwalter M.R., Laird M.E., Diamond M.S., Schwartz O., Albert M.L. Cutting edge: independent roles for IRF-3 and IRF-7 in hematopoietic and nonhematopoietic cells during host response to Chikungunya infection. J. Immunol. 2012, 188:2967-2971.
29. Schilte C., Couderc T., Chretien F., Sourisseau M., Gangneux N., Guivel-Benhassine F., Kraxner A., Tschopp J., Higgs S., Michault A., Arenzana-Seisdedos F., Colonna M., Peduto L., Schwartz O., Lecuit M., Albert M.L. Type I IFN controls chikungunya virus via its action on nonhematopoietic cells. J. Exp. Med. 2010, 207:429-442.
30. Schilte C., Staikowsky F., Couderc T., Madec Y., Carpentier F., Kassab S., Albert M.L., Lecuit M., Michault A. Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study. PLoS Negl. Trop. Dis. 2013, 7:e2137.
31. Schwartz O., Albert M.L. Biology and pathogenesis of chikungunya virus. Nat. Rev. Microbiol. 2010, 8:491-500.
32. Shirato K., Kimura T., Mizutani T., Kariwa H., Takashima I. Different chemokine expression in lethal and non-lethal murine West Nile virus infection. J. Med. Virol. 2004, 74:507-513.
33. Smith R.S., Smith T.J., Blieden T.M., Phipps R.P. Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. Am. J. Pathol. 1997, 151:317-322.
34. Spain-Santana T.A., Marglin S., Ennis F.A., Rothman A.L. MIP-1 alpha and MIP-1 beta induction by dengue virus. J. Med. Virol. 2001, 65:324-330.
35. Surasombatpattana P., Hamel R., Patramool S., Luplertlop N., Thomas F., Despres P., Briant L., Yssel H., Misse D. Dengue virus replication in infected human keratinocytes leads to activation of antiviral innate immune responses. Infect. Genet. Evol. 2011, 11:1664-1673.
36. Suthar M.S., Ramos H.J., Brassil M.M., Netland J., Chappell C.P., Blahnik G., McMillan A., Diamond M.S., Clark E.A., Bevan M.J., Gale M. The RIG-I-like receptor LGP2 controls CD8(+) T cell survival and fitness. Immunity 2012, 37:235-248.
37. Venugopalan A., Ghorpade R.P., Chopra A. Cytokines in acute chikungunya. PLoS ONE 2014, 9:e111305.
38. Werneke S.W., Schilte C., Rohatgi A., Monte K.J., Michault A., Arenzana-Seisdedos F., Vanlandingham D.L., Higgs S., Fontanet A., Albert M.L., Lenschow D.J. ISG15 is critical in the control of Chikungunya virus infection independent of UbE1L mediated conjugation. PLoS Pathog. 2011, 7:e1002322.
39. WHO, 2013. Chikungunya in the French part of the Caribbean isle of Saint Martin 2013. Global Alert and Response Disease Outbreak news AO December 2013 [internet]. Available from: http://www.who.int/csr/don/2013_12_10a/en/index.html.
40. Wikan N., Khongwichit S., Phuklia W., Ubol S., Thonsakulprasert T., Thannagith M., Tanramluk D., Paemanee A., Kittisenachai S., Roytrakul S., Smith D.R. Comprehensive proteomic analysis of white blood cells from chikungunya fever patients of different severities. J. Transl. Med. 2014, 12:96.
41. Wu M.F., Chen S.T., Yang A.H., Lin W.W., Lin Y.L., Chen N.J., Tsai I.S., Li L., Hsieh S.L. CLEC5A is critical for dengue virus-induced inflammasome activation in human macrophages. Blood 2013, 121:95-106.